Harrow Cash Flow Statement
NASDAQ: HROWHealth CareBiotechnology: Pharmaceutical PreparationsUSD
29.36-1.16 (-3.80%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Harrow free cash flow
In fiscal 2025, Harrow generated $43.9 million of operating cash flow and spent $887,000 on capital expenditures. That left free cash flow of $43.0 million, a free-cash-flow margin of 15.8% of revenue.
Summary generated from market data by MetaCap's automated system. Methodology
Harrow cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -5.14M | -17.48M | -24.41M | -14.09M | -18.01M | -3.42M | -125.00K | 14.63M | -11.98M | -19.09M |
| Net Income growth (YoY) | — | — | — | — | — | — | -100.85% | — | — | — |
| Depreciation & Amortization | 1.31M | 1.27M | 1.05M | 1.25M | 1.58M | 1.70M | 1.94M | 1.61M | 1.40M | 1.05M |
| Stock-Based Compensation | 12.50M | 17.62M | 15.70M | 7.97M | 5.75M | 2.77M | 1.79M | 2.49M | 2.94M | 3.67M |
| Change in Working Capital | -751.00K | -48.67M | -8.56M | -6.50M | -1.03M | -6.47M | -1.56M | 2.36M | 1.13M | -1.15M |
| Operating Cash Flow | 43.86M | -22.20M | 3.84M | 1.71M | 5.08M | -1.10M | 950.00K | 687.00K | -8.80M | -11.21M |
| Capital Expenditures | -887.00K | -1.59M | -1.46M | -2.60M | -1.79M | -862.00K | -1.47M | -1.77M | -772.00K | -6.89M |
| Investing Cash Flow | -5.46M | -33.16M | -152.55M | -1.74M | -18.69M | -981.00K | -1.83M | -2.20M | -961.00K | -7.29M |
| Debt Issued | 244.38M | 29.78M | 55.88M | — | — | — | — | — | — | — |
| Debt Repaid | -230.90M | — | -59.75M | — | — | — | — | — | — | — |
| Financing Cash Flow | -12.72M | 28.53M | 126.53M | 54.14M | 51.47M | 1.43M | -1.01M | 4.13M | 4.93M | 24.67M |
| Net Change in Cash | 25.68M | -26.84M | -22.18M | 54.10M | 37.87M | -648.00K | -1.89M | 2.62M | -4.83M | 6.17M |
| Free Cash Flow | 42.98M | -23.80M | 2.38M | -892.00K | 3.30M | -1.96M | -518.00K | -1.08M | -9.57M | -18.10M |
This table shows 10 annual periods of Harrow's cash flow statement, from FY 2025 back to FY 2016, across 13 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow HROW's reporting calendar. What is a cash flow statement?